The market for clostridium diagnostics is divided into segments based on technology, type, end user, and geography. The market is divided into immunoassays and molecular diagnostics based on technology. Clostridium difficile, clostridium perfringens, clostridium botulinum, Clostridium Difficile Diagnostics Market, and clostridium sordellii are the several product categories that make up the market.
One of the main etiological agents for hospital-acquired infections worldwide, particularly in the US, is Clostridium difficile. Pseudomembranous colitis and protracted diarrhoea are two symptoms of the disease, which frequently affects individuals who have recently visited a hospital or who have taken antibiotics for an extended period of time.
Read More @ https://cmiinfonest.blogspot.com/2023/03/clostridium-difficile-diagnostics.html
